IDEXX Laboratories Director Lawrence Kingsley Exercises and Sells $1.17M in Stock
IDEXX LABORATORIES INC /DE
Subscribe to track IDXX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š Form 4 Filing Alert: IDXX š¤ Insider: Lawrence D. Kingsley (Director) š Action: Option Exercise & Sale š Shares Sold: 2,203 @ $532.08 ($1,172,177.97 total value) š¼ Shares Remaining: 9,568 direct shares š Transaction Date: September 4, 2026
Comprehensive Analysis
Executive Summary
On September 4, 2026, Lawrence D. Kingsley, a Director of IDEXX Laboratories, Inc. (NASDAQ: IDXX), executed a routine stock option exercise and subsequent open-market sale of 2,203 shares of common stock.
Transaction Breakdown
- Option Exercise (Code M): Exercised 2,203 non-qualified stock options at a strike price of $114.17 per share.
- Open-Market Sale (Code S): Disposed of 2,203 shares at a volume-weighted average price of $532.0826 (range: $531.88 - $532.14) for total gross proceeds of approximately $1,172,178.
- Net Cash Proceeds Before Tax/Fees: ~$920,661.
- Post-Transaction Holdings: Retains direct ownership of 9,568 common shares.
Strategic & Market Context
- Expiring Options: The underlying stock options were granted with a vesting date in May 2017 and were set to expire on November 30, 2026. This indicates the transaction was primarily driven by the approaching expiration date rather than a sentiment shift regarding company valuation.
- Significance: Classified as Low significance due to the standard exercise-and-sell nature typical for expiring director equity awards.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.